United Drug reports H1 profits increase

United Drug has reported adjusted pre-tax profits of €35m for the six months to end March, a 7% increase on the same period last year.

In an interim management statement issued this morning, the company said revenues for the period were flat at €894.2m but earnings per share were up 8%.